Eli Lilly and Company - SWOT Analysis

Eli Lilly and Company - SWOT Analysis
  • Report price : $ 125
  • Publication date : March 2008
  • Length : 54 pages

Get this Report Now !

Eli Lilly and Company - SWOT Analysis

Datamonitor's Eli Lilly and Company - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Eli Lilly and Company (Lilly) is a global, research-based pharmaceutical company, headquartered in the US. The company has approximately 41,350 employees worldwide and its products are marketed in 143 countries. The company recorded revenues of $15,691 million during the fiscal year ended December 2006, an increase of 7.1% over 2005. The increase was primarily attributable to strong sales performance of Cymbalta, Forteo, Byetta, Zyprexa, and Alimta. The operating profit of the company was $3,180.2 million during fiscal year 2006, an increase of 32.3% over 2005. The net profit was $2,662.7 million in fiscal year 2006, an increase of 34.5% over 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

AstraZeneca PLC - SWOT Analysis

AstraZeneca PLC - SWOT Analysis

  • $ 125
  • March 2008
  • 45 pages

Datamonitor's AstraZeneca PLC - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Ast ...

Industries : Pathology | Countries : USA, Sweden, United Kingdom

Amylin Pharmaceuticals Inc - SWOT Analysis

Amylin Pharmaceuticals Inc - SWOT Analysis

  • $ 125
  • March 2008
  • 37 pages

Datamonitor's Amylin Pharmaceuticals Inc - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...

Industries : Pathology | Countries : USA, Germany

CuraGen Corporation - SWOT Analysis

CuraGen Corporation - SWOT Analysis

  • $ 125
  • March 2008
  • 37 pages

Datamonitor's CuraGen Corporation - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ...

Industries : Pathology | Countries : USA

Global Dialysis Market: Hemodialysis Continues to be the Preferred Treatment Method

Global Dialysis Market: Hemodialysis Continues to be the Preferred Treatment Method

  • $ 850
  • January 2008
  • 30 pages

Public healthcare programs reimburse costs for majority of dialysis treatments in the United States and in Western Europe. The governments of these regions are considering proposals for controlling costs by altering the public-sponsored healthcare programs. This move is likely to change the profita ...

Industries : Medical Devices, Pathology, Healthcare | Countries : USA

The World Hypertension Market 2007-2023

The World Hypertension Market 2007-2023

  • $ 3 621
  • September 2007
  • 200 pages

The market for hypertensives - led by the angiotensin II antagonists - is one of the largest and most profitable in the global pharmaceutical market, with total anti-hypertensive sales of $36600m in 2006. Hypertension, or high blood pressure, is a worldwide epidemic: by 2025 visiongain predict that ...

Industries : Pathology | Countries : USA, Japan

Vaccines

Vaccines

  • $ 750
  • March 2008
  • 143 pages

Vaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand. While governments are reluctant to ensure steady demand for vaccines unless the manufacturers can prove their ability to increase their supply, the latter are apprehensive a ...

Industries : Pathology | Countries : USA, India

Personal Protective Equipment : Spain

Personal Protective Equipment : Spain

  • $ 2 181
  • February 2008
  • 182 pages

In this report, now available in English for the first time, MSI analyses the Spanish personal protective equipment market for a five-year review period (2003-2007) and a five year forecast period up until 2012. Our regular clients asked us to produce an English version of our detailed market study, ...

Industries : Clothing Accessories, Security Services, Pathology, Clothing and Textile | Countries : USA, Spain, United Kingdom

Pet Insurance in North America, 3rd Edition

Pet Insurance in North America, 3rd Edition

  • $ 3 300
  • January 2008

Pet Insurance in North America, 3rd Edition If the future of this market depends on marketing-driven consumer demand, as Packaged Facts believes it does and history supports, then the North American market for pet insurance is at a pivotal stage. Since the previous edition of this report, published ...

Industries : Wireless Technology, Pathology, Health Insurance, Pharmaceutical | Countries : Canada, USA

The Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

The Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

  • $ 4 100
  • January 2008

Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008. Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last year, new products and better than expected p ...

Industries : Pathology | Countries : USA

World Cardiovascular Disease Diagnostics Markets

World Cardiovascular Disease Diagnostics Markets

  • $ 3 950
  • March 2008
  • 415 pages

This report analyzes the worldwide markets for Cardiovascular Disease Diagnostics in Millions of US$. The major product segments analyzed are In Vitro Diagnostics, and In Vivo Diagnostics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle Ea ...

Industries : Pathology, Medical Devices | Countries : Canada, USA, China, Japan, Russia, Germany, Spain, France, Italy, United Kingdom, Switzerland

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.